The weekly litigation news digest is live. Subscribe now

IP Verse

Permanent Gene Correction By Means Of Nucleotide-Modified Messenger Rna - EP3054993

The patent EP3054993 was granted to Eberhard Karls Universitt Tbingen Medizinische Fakultt on Dec 4, 2019. The application was filed on Oct 6, 2014 under application number EP14781175A. The patent is currently recorded with a legal status of "Revoked".

EP3054993

EBERHARD KARLS UNIVERSITT TBINGEN MEDIZINISCHE FAKULTT
Application Number
EP14781175A
Filing Date
Oct 6, 2014
Status
Revoked
Jan 14, 2022
Publication Date
Dec 4, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
WUESTHOFF & WUESTHOFF PATENTANWALTE PARTG MBBSep 3, 2020WICHMANNADMISSIBLE

Patent Citations (10) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2013117870
DESCRIPTIONWO2011012316
INTERNATIONAL-SEARCH-REPORTUS2013117870
INTERNATIONAL-SEARCH-REPORTWO2007024708
OPPOSITIONDE102013111099
OPPOSITIONUS2012195936
OPPOSITIONUS2013117870
OPPOSITIONWO2013063315
OPPOSITIONWO2014186585
OPPOSITIONWO2015052133

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents